Randomized, Controlled Study of the Safety and Immunogenicity of Peru-15, a Live Attenuated Oral Vaccine Candidate for Cholera, in Adult Volunteers in Bangladesh

BackgroundA live oral Vibrio cholerae O1 El Tor vaccine candidate, Peru-15, was studied for safety, immunogenicity, and excretion in phase 1 (inpatient) and phase 2 (outpatient) studies of Bangladeshi adults MethodsThe study was conducted among adults, by use of a double-blind, randomized, placebo-c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infectious diseases 2005-08, Vol.192 (4), p.573-579
Hauptverfasser: Qadri, Firdausi, Chowdhury, Mohiul I., Faruque, Shah M., Salam, Mohammed A., Ahmed, Tanvir, Begum, Yasmin A., Saha, Amit, Alam, Mohammed S., Zaman, K., Seidlein, Lorenz V., Park, Eunsik, Killeen, Kevin P., Mekalanos, John J., Clemens, John D., Sack, David A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!